Compositions for treating wounds
OwnerSamuel E. LYNCH, Leslie WISNER-LYNCHinventors
Life of this patent
Estimating the term…
Abstract
Novel compositions for treating wounds and promoting the healing thereof are described, including composition containing novel combinations of a carrier and recombinant platelet derived growth factor having fewer isoforms and enhanced biostability. Methods of treating wounds with novel therapeutic composition using doing procedures leading to effective results with a minimal number of treatment applications are also described.
Claims15
A lyophilized therapeutic composition for treating wounds consisting essentially of recombinant human platelet-derived growth factor (rhPDGF), incorporated into a biocompatible matrix, wherein the lyophilized therapeutic composition is formed from a rhPDGF solution disposed in a sterile porous biocompatible matrix, wherein:
- a) the rhPDGF solution contains between 0.05 mg/ml to 5 mg/ml of rhPDGF in a buffer;
- b) wherein the porous biocompatible matrix consists of a natural polymer selected from the group consisting of collagen, gelatin, fibrin, alginate, cellulose, chitosan and fibronectin;
- c) wherein the porous biocompatible matrix includes an open porous structure that allows for cell attachment and ingrowth into the pores, wherein the pores have a pore size distribution of between about 5 μm to about 1000 μm or an average pore size of between 50 μm and 500 μm, and wherein said pores entrap at least about 20% of said rhPDGF within said pores;
- and
- d) wherein the ratio of rhPDGF solution to matrix is between about 0.05 ml/cm3 to about 5 ml/cm3.
Dependencies are inferred from the claim text.